These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 38371081)

  • 1. Nonhormonal Pharmacotherapies for the Treatment of Postmenopausal Vasomotor Symptoms.
    Witten T; Staszkiewicz J; Gold L; Granier MA; Klapper RJ; Lavespere G; Dorius B; Allampalli V; Ahmadzadeh S; Shekoohi S; Kaye AD; Varrassi G
    Cureus; 2024 Jan; 16(1):e52467. PubMed ID: 38371081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The efficacy and tolerability of SSRI/SNRIs in the treatment of vasomotor symptoms in menopausal women: a systematic review.
    Handley AP; Williams M
    J Am Assoc Nurse Pract; 2015 Jan; 27(1):54-61. PubMed ID: 24944075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Do SSRIs and SNRIs reduce the frequency and/or severity of hot flashes in menopausal women.
    Stubbs C; Mattingly L; Crawford SA; Wickersham EA; Brockhaus JL; McCarthy LH
    J Okla State Med Assoc; 2017 May; 110(5):272-274. PubMed ID: 28649145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New pharmacological therapies for vasomotor symptom management: focus on bazedoxifene/conjugated estrogens and paroxetine mesylate.
    Carris N; Kutner S; Reilly-Rogers S
    Ann Pharmacother; 2014 Oct; 48(10):1343-9. PubMed ID: 25028744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Managing vasomotor symptoms in women after cancer.
    Pinkerton JV; Santen RJ
    Climacteric; 2019 Dec; 22(6):544-552. PubMed ID: 31081391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of Menopausal Symptoms: A Review.
    Crandall CJ; Mehta JM; Manson JE
    JAMA; 2023 Feb; 329(5):405-420. PubMed ID: 36749328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serotonergic agents as an alternative to hormonal therapy for the treatment of menopausal vasomotor symptoms.
    Stearns V
    Treat Endocrinol; 2006; 5(2):83-7. PubMed ID: 16542048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurokinin 3 Receptor Antagonists Compared With Serotonin Norepinephrine Reuptake Inhibitors for Non-Hormonal Treatment of Menopausal Hot Flushes: A Systematic Qualitative Review.
    Menown SJ; Tello JA
    Adv Ther; 2021 Oct; 38(10):5025-5045. PubMed ID: 34514552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Headache and hormone replacement therapy in the postmenopausal woman.
    MacGregor EA
    Curr Treat Options Neurol; 2009 Jan; 11(1):10-7. PubMed ID: 19094831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hormonal and nonhormonal treatment of vasomotor symptoms.
    Krause MS; Nakajima ST
    Obstet Gynecol Clin North Am; 2015 Mar; 42(1):163-79. PubMed ID: 25681847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) for the prevention of migraine in adults.
    Banzi R; Cusi C; Randazzo C; Sterzi R; Tedesco D; Moja L
    Cochrane Database Syst Rev; 2015 Apr; 4(4):CD002919. PubMed ID: 25829028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EMAS position statement: Non-hormonal management of menopausal vasomotor symptoms.
    Mintziori G; Lambrinoudaki I; Goulis DG; Ceausu I; Depypere H; Erel CT; Pérez-López FR; Schenck-Gustafsson K; Simoncini T; Tremollieres F; Rees M
    Maturitas; 2015 Jul; 81(3):410-3. PubMed ID: 25982505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Ovarian Ablation in Breast Cancer Patients and the Possibility of Influencing Treatment Side Effects].
    Palácová M
    Klin Onkol; 2016; 29 Suppl 3():S29-38. PubMed ID: 28118722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative efficacy of nonhormonal drugs on menopausal hot flashes.
    Li L; Xu L; Wu J; Dong L; Zhao S; Zheng Q
    Eur J Clin Pharmacol; 2016 Sep; 72(9):1051-8. PubMed ID: 27450233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Efficacy and Safety of Selective Serotonin Reuptake Inhibitors and Serotonin-Norepinephrine Reuptake Inhibitors in the Treatment of Menopausal Hot Flashes: A Systematic Review of Clinical Trials.
    Azizi M; Khani S; Kamali M; Elyasi F
    Iran J Med Sci; 2022 May; 47(3):173-193. PubMed ID: 35634530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of menopause-associated vasomotor symptoms: position statement of The North American Menopause Society.
    North American Menopause Society
    Menopause; 2004; 11(1):11-33. PubMed ID: 14716179
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonhormonal therapies for menopausal hot flashes: systematic review and meta-analysis.
    Nelson HD; Vesco KK; Haney E; Fu R; Nedrow A; Miller J; Nicolaidis C; Walker M; Humphrey L
    JAMA; 2006 May; 295(17):2057-71. PubMed ID: 16670414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Critical appraisal of paroxetine for the treatment of vasomotor symptoms.
    Carroll DG; Lisenby KM; Carter TL
    Int J Womens Health; 2015; 7():615-24. PubMed ID: 26124682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New generation nonhormonal management for hot flashes.
    Imai A; Matsunami K; Takagi H; Ichigo S
    Gynecol Endocrinol; 2013 Jan; 29(1):63-6. PubMed ID: 22809093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relapse of vasomotor symptoms after discontinuation of the selective serotonin reuptake inhibitor escitalopram: results from the menopause strategies: finding lasting answers for symptoms and health research network.
    Joffe H; Guthrie KA; Larson J; Cohen LS; Carpenter JS; Lacroix AZ; Freeman EW
    Menopause; 2013 Mar; 20(3):261-8. PubMed ID: 23435022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.